Product Name

Brimonidine Tartrate

Name: Brimonidine Tartrate - LGM Pharma
SKU: 79570-19-7

CAS Number

79570-19-7

LGM Pharma is an API distributor. LGM Pharma supplies APIs as per CGMP with DMF support, subject to availability and manufacturer requirements. LGM Pharma does not sell or supply APIs or finished dosage products to individual patients, doctors, or pharmacies.

Questions? Call our customer API support number 1-(800)-881-8210

Product Name:

Brimonidine Tartrate

CAS Number:

79570-19-7

Indication:

The ophthalmic solution is indicated for patients with open-angle glaucoma or ocular hypertension to lower intraocular pressure. The topical gel is indicated for the treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years or older.

Mode of Action:

Brimonidine is an alpha adrenergic receptor agonist (primarily alpha-2). It has a peak ocular hypotensive effect occurring at two hours post-dosing. Fluorophotometric studies in animals and humans suggest that Brimonidine has a dual mechanism of action by reducing aqueous humor production and increasing uveoscleral outflow. The topical gel reduces erythema through direct vasocontriction.

Pharmacodynamics:

Brimonidine significantly lowers intraocular pressure with minimal effects on cardiovascular and pulmonary parameters. It lowers intraocular pressure by reducing aqueous humor production and increasing uveoscleral outflow.

Metabolism:

Metabolized primarily by the liver.

Toxicity:

Oral LD50 is 50 mg/kg in mice and 100 mg/kg in rats. Common adverse reactions of the topical gel formulation include erythema, flushing, skin burning sensation, and contact dermatitis.

IUPAC:

5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine

ATC:

D11AX21 — Brimonidine, S01EA05 — Brimonidine

PubChem:

2435

DrugBank:

DB00484 (APRD00034)

Formula:

C11H10BrN5

Molecular Mass:

292.135

Synonyms:

5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline, Brimonidina, Brimonidine, Brimonidinum, Bromoxidine

SMILES:

BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12

AHFS Code:

52:40.04 — Alpha-adrenergic Agonists, 84:92.00 — Misc. Skin and Mucous Membrane Agents

InChi:

InChI=1S/C11H10BrN5/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8/h1-4H,5-6H2,(H2,15,16,17)

Date Modified:

03-12-19

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

LGM currently offers Monoclonal Antibodies (mAbs) for non-GMP/R&D use. Please inquire about Monoclonal Antibodies produced under GMP conditions.

Questions? Call our customer API support number 1-(800)-881-8210.

Ask us about this product

API’s From Quality Manufacturers:

Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
Premium quality GMP certified and fully accredited API manufacturing plants
Technical packages as well as access to filed DMF, ASMF or CEP (subject to availability)
Regulatory and technical assistance towards any submission type based on specific customer requirements

Brimonidine Tartrate

79570-19-7

Ask us about this product

API’s From Quality Manufacturers:

Find an API Product